Acute Lymphoblastic Leukemia ALL research hub
3 indexed studies · 3 currently recruiting
- not yet recruitingNA
Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
This study looks into why some children with a type of blood cancer called ALL have bad reactions to a key medicine, asparaginase. Researchers are studying how immune cells react to the drug to find ways to predict and prevent these reactions, making treatment safer.
France - not yet recruitingPHASE2, PHASE3
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
This study looks at new ways to make stem cell transplants safer and more effective for children and young people with a type of blood cancer called ALL. Researchers want to reduce serious side effects and improve long-term health for these patients.
Austria · Czechia · Denmark - recruitingPHASE2
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
This study looks at new ways to treat children and teenagers with a type of blood cancer called acute lymphoblastic leukemia (ALL) that has come back. It investigates a new drug called Bortezomib to see if it can help improve treatment success for those with high-risk relapsed ALL.
Australia · Austria · Belgium